Intestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study

Yuichi Matsuno, Takehiro Torisu, Junji Umeno, Hiroki Shibata, Atsushi Hirano, Yuta Fuyuno, Yasuharu Okamoto, Shin Fujioka, Keisuke Kawasaki, Tomohiko Moriyama, Tomohiro Nagasue, Keizo Zeze, Yoichiro Hirakawa, Shinichiro Kawatoko, Yutaka Koga, Yoshinao Oda, Motohiro Esaki, Takanari Kitazono

Intest Res. 2022;20(2):260-268. Published online April 29, 2022
DOI: https://doi.org/10.5217/ir.2021.00124

One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study

Intestinal Research. 2022;20(2):260-268

Link1

Link2 Link3

P732 The clinical efficacy and safety of indigo naturalis in induction & maintenance therapy for moderate-to-severe ulcerative colitis: A single-centre prospective uncontrolled open-label study

Y Matsuno, A Hirano, T Torisu, Y Fuyuno, Y Okamoto, F Shin, M Tomohiko, J Umeno, Y Hirakawa, M Esaki, T Kitazono

Journal of Crohn's and Colitis. 2020;14(Supplement_1):S588-S588

Link1

Link2

Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial

Kan Uchiyama, Shinichiro Takami, Hideo Suzuki, Kiyotaka Umeki, Satoshi Mochizuki, Nobushige Kakinoki, Junichi Iwamoto, Yoko Hoshino, Jun Omori, Shunji Fujimori, Akinori Yanaka, Yuji Mizokami, Toshifumi Ohkusa

PLOS ONE. 2020;15(11):e0241337

Link1

Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centers

Beatrice Orlandini, Gabriele Dragoni, Angela Variola, Arianna Massella, Siro Bagnoli, Riccardo Campi, Francesca Rogai

Journal of Digestive Diseases. 2018;19(8):468-474

Link1 Link2

P662 Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study

N Yoshimura, Soh Okano, Minako Sako, Masakazu Takazoe

Journal of Crohn's and Colitis. 2020;14(Supplement_1):S545-S545

Link1

Link2

TCT-255: Consistent Efficacy and Safety of Everolimus-Eluting Stents In 5054 Patients From a Large Prospective Real World Study: One-Year Clinical Outcomes From the XIENCE V ® USA Study

Journal of the American College of Cardiology. 2010;56(13):B59

Link1 Link2

Sa1749 - Indigo Naturalis is Effective in Treatment-Refractory Patients with Ulcerative Colitis: Post-HOC Analysis from Indigo Study

Makoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, Taku Kobayashi, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Kenji Watanabe, Takayuki Abe, Toshifumi Hibi, Yasuo Suzuki, Takanori Kanai

Gastroenterology. 2018;154(6):S-380

Link1 Link2

Efficacy of Rebamipide Enemas in Active Distal Ulcerative Colitis and Proctitis: A Prospective Study Report

G.R. Lichtenstein

Yearbook of Gastroenterology. 2006;2006:143-144

Link1 Link2

Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis

Stephan Böhm, Wolfgang Kruis

Clinical and Experimental Gastroenterology. 2014;369

Link1

P549 One-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib Versus Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States

R Dalal, P Sharma, K Bains, J Pruce, J Allegretti

Journal of Crohn's and Colitis. 2023;17(Supplement_1):i677-i678

Link1

Link2